High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: A prospective interventional study

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 7-8, 2013, Pages 533-536

  Dorst, Johannes ^a   Cypionka, Joschka ^a   Ludolph, Albert C ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Amyotrophic lateral sclerosis; BMI; Carbohydrate; Fat; Food supplement

Indexed keywords

CARBOHYDRATE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FAT CONTENT; FEMALE; HUMAN; LIPID DIET; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; VITAL CAPACITY;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BODY WEIGHT; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY SUPPLEMENTS; EARLY MEDICAL INTERVENTION; ENERGY INTAKE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84887486310     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.823999     Document Type: Article

References (13)

1. Truong TC, Vallat J M, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999; 53:1059-63.
2. Genton L, Viatte V, Janssens JP, Hé ritier A C, Pichard C. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Clin Nutr. 2011; 30:553-9.
3. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufr è re B, Couratier P. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001; 74:328-34.
4. Braun MM, Osecheck M, Joyce NC. N utrition assessment and management in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am. 2012; 23:751-71.
5. Dupuis L, Oudart H, Ren é F, Gonzalez de Aguilar JL, Loeffl er JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefi t of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA. 2004; 101:11159-64.
6. Dupuis L, Corcia P, Fergani A, Gonzalez de Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidaemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008; 70:1004-9.
7. Dorst J, Kü hnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011; 258:613-7.
8. Chio A, Calvo A, Ilardi A, Cavallo E, Moglia C, Mutani R, et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology. 2009; 73:1681-5.
9. Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidaemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011; 44:20-4.
10. Lopez Gomez JJ, Ballesteros Pomar MD, Vazquez Sanchez F, Vidal Casariego A, Calleja Fernandez A, Cano Rodriguez I. Effect of nutritional support on survival in patients with amyotrophic lateral sclerosis. Nutr Hosp. 2011; 26:515-21.
11. Brooks BR, Miller RG, Swash M, Munsat T L. et al Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1:293-9.
12. Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol. 2012; 19:360-75.
13. Holm T, Maier A, Wicks P, Lang D, Linke P, Mü nch C, et al. Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study. Interact J Med Res. 2013; 2:e8.